Justin Klee and Josh Cohen had pulled off an improbable success, turning an idea they hashed out as undergraduates into a drug that aimed to slow one of the world’s most implacable and deadly neurological diseases.
Democracy Dies in Darkness
Failure of ALS drug puts a spotlight on controversial FDA approvals
Critics say the Food and Drug Administration has gone too far greenlighting drugs despite concerns about their effectiveness
March 16, 2024 at 6:00 a.m. EDT